GlassScriptPhysician profile
Raffaella Pascarella
NPI 1881075323
$4,044.73
in general payments reported to CMS, 2019-2025
32 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $653 · 2020: $313 · 2021: $421 · 2022: $266 · 2023: $791 · 2024: $1,283 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,391.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $912.22 | 2019-2024 | Hoffmann, Augment Injectable, Biofoam |
| Kerecis Limited | $474.58 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $273.74 | 2020-2025 | Panta 2, Small Cannulated Screws, Cannulated Screws |
| Solventum Corporation | $197.88 | 2024-2025 | Prevena Restor Axioform, V.A.C. Veraflo Cleanse Choice, Activ.A.C. |
| Abbvie INC. | $182.00 | 2022-2024 | |
| Organogenesis INC. | $165.82 | 2019-2022 | |
| Next Science LLC | $155.91 | 2023-2024 | Xperience, Surgx, Blastx |
| Paratek Pharmaceuticals, INC. | $145.04 | 2023-2025 | Nuzyra |
| Integra Lifesciences Corporation | $139.77 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $137.84 | 2020-2023 | Jublia |
| Treace Medical Concepts, INC. | $134.64 | 2024 | |
| Depuy Synthes Sales INC. | $129.62 | 2024 | Motoband, Minibunion, Motoband Cp |
| Osiris Therapeutics INC. | $121.57 | 2019 | |
| Orthofix Medical, INC. | $113.78 | 2023-2024 | Physio-Stim, Accelstim |
| Musculoskeletal Transplant Foundation INC. | $109.74 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $94.24 | 2021-2023 | Activ.A.C. |
| Voom Medical Devices, INC. | $77.84 | 2025 | Revcon Instrument Kit, Sterile, Revcon |
| Globus Medical, INC. | $71.42 | 2021 | |
| Averitas Pharma INC. | $59.11 | 2023 | Qutenza |
| Wright Medical Technology, INC. | $55.78 | 2019 | |
| Bioventus LLC | $48.56 | 2023 | Exogen Ultrasound Bone Healing System |
| Grt US Holding, INC. | $44.81 | 2021-2022 | |
| Mimedx Group, INC. | $25.63 | 2024 | |
| Osteomed LLC | $24.13 | 2019 | |
| Baudax Bio INC. | $23.35 | 2021 | |
| Heron Therapeutics, INC. | $21.90 | 2021 | |
| Reprise Biomedical, INC. | $21.09 | 2024 | Miro3d |
| In2bones USA, LLC | $20.64 | 2019 | |
| Zimvie INC. | $17.37 | 2023 | |
| Amgen INC. | $15.76 | 2025 | Krystexxa |
| Horizon Therapeutics Plc | $14.92 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raffaella Pascarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.